Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

Stephen Reynolds, fresh from his latest harvest, says he is busier than he has ever been. At 52, working long hours farming ...

Health service announces three-year safety improvement programme to ensure patients receive critical medicine on time ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...